Evaluation of 3-carbamoylpropanoic acid analogs as inhibitors of human hypoxia-inducible factor (HIF) prolyl hydroxylase domain enzymes
- 3 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Medicinal Chemistry Research
- Vol. 30 (4), 977-986
- https://doi.org/10.1007/s00044-020-02681-7
Abstract
No abstract availableKeywords
Funding Information
- Research University Grant (1001.PKIMIA.811250)
This publication has 45 references indexed in Scilit:
- Inhibition of 2-oxoglutarate dependent oxygenasesChemical Society Reviews, 2011
- Prolyl hydroxylase domain-containing protein inhibitors as stabilizers of hypoxia-inducible factor: small molecule-based therapeutics for anemiaExpert Opinion on Therapeutic Patents, 2010
- Small-Molecule-Based Inhibition of Histone Demethylation in Cells Assessed by Quantitative Mass SpectrometryJournal of Proteome Research, 2010
- The impact of O2 availability on human cancerNature Reviews Cancer, 2008
- Cell-Permeable Esters of Diazeniumdiolate-Based Nitric Oxide ProdrugsOrganic Letters, 2008
- Regulation of angiogenesis by hypoxia-inducible factor 1Critical Reviews in Oncology/Hematology, 2006
- Cellular oxygen sensing: Crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2)Proceedings of the National Academy of Sciences of the United States of America, 2006
- Regulation of hypoxia-inducible factor 1 by prolyl and asparaginyl hydroxylasesBiochemical and Biophysical Research Communications, 2005
- Brain Genomic Response following Hypoxia and Re-oxygenation in the Neonatal RatOnline Journal of Public Health Informatics, 2002
- Hypoxia Inducible Factor-α Binding and Ubiquitylation by the von Hippel-Lindau Tumor Suppressor ProteinOnline Journal of Public Health Informatics, 2000